Literature DB >> 29778688

Molecular basis of diseases caused by the mtDNA mutation m.8969G>A in the subunit a of ATP synthase.

Natalia Skoczeń1, Alain Dautant2, Krystyna Binko1, François Godard2, Marine Bouhier2, Xin Su3, Jean-Paul Lasserre2, Marie-France Giraud2, Déborah Tribouillard-Tanvier2, Huimei Chen4, Jean-Paul di Rago5, Roza Kucharczyk6.   

Abstract

The ATP synthase which provides aerobic eukaryotes with ATP, organizes into a membrane-extrinsic catalytic domain, where ATP is generated, and a membrane-embedded FO domain that shuttles protons across the membrane. We previously identified a mutation in the mitochondrial MT-ATP6 gene (m.8969G>A) in a 14-year-old Chinese female who developed an isolated nephropathy followed by brain and muscle problems. This mutation replaces a highly conserved serine residue into asparagine at amino acid position 148 of the membrane-embedded subunit a of ATP synthase. We showed that an equivalent of this mutation in yeast (aS175N) prevents FO-mediated proton translocation. Herein we identified four first-site intragenic suppressors (aN175D, aN175K, aN175I, and aN175T), which, in light of a recently published atomic structure of yeast FO indicates that the detrimental consequences of the original mutation result from the establishment of hydrogen bonds between aN175 and a nearby glutamate residue (aE172) that was proposed to be critical for the exit of protons from the ATP synthase towards the mitochondrial matrix. Interestingly also, we found that the aS175N mutation can be suppressed by second-site suppressors (aP12S, aI171F, aI171N, aI239F, and aI200M), of which some are very distantly located (by 20-30 Å) from the original mutation. The possibility to compensate through long-range effects the aS175N mutation is an interesting observation that holds promise for the development of therapeutic molecules.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP synthase; MT-ATP6; Metabolic disease; Oxidative phosphorylation; Subunit a; mtDNA

Mesh:

Substances:

Year:  2018        PMID: 29778688     DOI: 10.1016/j.bbabio.2018.05.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta Bioenerg        ISSN: 0005-2728            Impact factor:   3.991


  5 in total

1.  Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity.

Authors:  Simon Berhe; Matthew M Heeney; Dean R Campagna; John F Thompson; Eric J White; Tristen Ross; Roy W A Peake; Jeffery D Hanrahan; Vilmarie Rodriguez; Deborah L Renaud; Mrinal S Patnaik; Eugenia Chang; Sylvia S Bottomley; Mark D Fleming
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

2.  Creation of Yeast Models for Evaluating the Pathogenicity of Mutations in the Human Mitochondrial Gene MT-ATP6 and Discovering Therapeutic Molecules.

Authors:  Tribouillard-Tanvier Déborah; Dautant Alain; Godard François; Panja Chiranjit; di Rago Jean-Paul; Kucharczyk Roza
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

4.  The pathogenic m.8993 T > G mutation in mitochondrial ATP6 gene prevents proton release from the subunit c-ring rotor of ATP synthase.

Authors:  Xin Su; Alain Dautant; Malgorzata Rak; François Godard; Nahia Ezkurdia; Marine Bouhier; Maïlis Bietenhader; David M Mueller; Roza Kucharczyk; Jean-Paul di Rago; Déborah Tribouillard-Tanvier
Journal:  Hum Mol Genet       Date:  2021-04-27       Impact factor: 6.150

5.  Molecular Basis of the Pathogenic Mechanism Induced by the m.9191T>C Mutation in Mitochondrial ATP6 Gene.

Authors:  Xin Su; Alain Dautant; François Godard; Marine Bouhier; Teresa Zoladek; Roza Kucharczyk; Jean-Paul di Rago; Déborah Tribouillard-Tanvier
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.